We came across a bullish thesis on Align Technology, Inc. (ALGN) on DIY Investor’s Substack. In this article, we will summarize the bulls’ thesis on ALGN. Align Technology, Inc. (ALGN)’s share was trading at $188.07 as of 10th June. ALGN’s trailing and forward P/E were 32.9 and 17.7 respectively according to Yahoo Finance
Here’s a rewritten and expanded version of the article, tailored for clarity, depth, and reader engagement, while preserving the financial and strategic insights on Align Technology:
Top 15 Countries for Dental Tourism — Plus a Look at Align Technology’s Investment Potential
A confident smile is not only a sign of good dental health but also increasingly a symbol of cutting-edge dental innovation. With the growing trend of dental tourism—where patients travel abroad for affordable yet high-quality care—many are also turning their eyes to the companies behind the technologies that make these dental transformations possible. One such standout is Align Technology (NASDAQ: ALGN), the global leader behind Invisalign, the clear aligner brand trusted by millions.
While this article highlights the top 15 destinations for dental tourism, it also takes a deeper look into the financials and investment case of Align Technology—a company shaping the future of orthodontics worldwide.
Align Technology: Dominating the Clear Aligner Market
Align Technology holds over 90% market share in the clear aligner industry—a testament to its strong brand, proprietary materials, and long-standing industry relationships. Founded over 25 years ago, Align pioneered the clear aligner revolution and has continuously innovated with products like SmartTrack material, iTero scanners, and its digital treatment planning tools.
Once considered a high-flying growth stock, ALGN traded at lofty valuations in its prime. In 2018, the company reached a price-to-earnings (P/E) ratio of 80x, driven by investor enthusiasm and the company’s rapid growth. Even during its “normalized” growth phase, the stock maintained a high multiple—hovering around 32x P/E.
A Valuation Reset—and a More Attractive Entry Point
Today, Align Technology’s stock presents a very different picture. Despite doubling its earnings over the past few years, the stock has undergone a steep correction due to valuation concerns and broader macroeconomic headwinds. Currently trading at around 18x forward P/E, the stock is notably cheaper than its historical average.
Market consensus expects approximately 10% annual earnings growth for the next three years—driven by increased global adoption of clear aligners, digital dentistry trends, and product expansion.
Fair Value Estimate & Upside Potential
Using a conservative approach, an investor could estimate a fair value of $200 per share, based on a projected EPS of $10.80 and normalized P/E ratios. With shares trading around $180, this implies roughly 10–12% annual return potential if valuation multiples remain steady.
Additionally, Morningstar assigns Align a fair value of $240 and a “narrow moat” rating, highlighting the company’s brand strength and switching costs, though acknowledging risks from economic cycles and increasing competition.
What Makes Align’s Moat Unique?
Align Technology’s competitive advantage lies in its intangible assets and network effects:
-
SmartTrack® material: Patented aligner material offering superior elasticity and performance.
-
Massive clinical data: Over 25 years of orthodontic cases enhance treatment precision.
-
High switching costs: Dentists and orthodontists trained on Invisalign systems are unlikely to switch to competitors.
-
Digital ecosystem: Integration of iTero scanners, treatment simulation software, and aligner production improves patient outcomes and practitioner efficiency.
Unlike some competitors, Align doesn’t rely on cost leadership. Instead, it excels through brand strength, proprietary technology, and R&D.
Strategic Acquisitions & Capital Discipline
Align has been highly strategic in its growth approach. The acquisition of Exocad, a leader in dental CAD/CAM software, expanded its digital dentistry capabilities and complemented its core aligner business.
In terms of capital management:
-
The company carries minimal debt
-
It reinvests heavily into R&D and innovation
-
It maintains a long-term growth posture, avoiding large-scale stock buybacks or dividends
Investor Outlook: A Quality Growth Play at a Reasonable Price
For long-term investors, Align offers a compelling blend of quality and value. While the clear aligner market may experience cyclicality tied to consumer discretionary spending, Align’s fundamentals remain strong. It’s a leader in a growing global niche with durable advantages and disciplined capital allocation.
Key Risks:
-
Macroeconomic pressures impacting elective dental procedures
-
Rising competition in the clear aligner space
-
Regulatory and insurance changes in international markets
Yet for those willing to embrace moderate volatility, Align appears poised for a rebound, offering an opportunity to buy a high-quality business at a reasonable valuation.
Previously Featured: Comparing Defensive vs Growth Investments
In an earlier piece, we explored Librarian Capital’s bullish thesis on Procter & Gamble (PG)—a defensive powerhouse known for stable cash flows and brand strength in consumer goods. In contrast, Align Technology, as outlined by DIY Investor, presents a growth-oriented case, driven by technological innovation, market leadership, and valuation reset.
Both companies are strong in their respective sectors, but Align offers more upside potential for growth-focused investors seeking exposure to the future of digital health and dentistry.
Align Technology, Inc. (ALGN) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 52 hedge fund portfolios held ALGN at the end of the first quarter which was 58 in the previous quarter. While we acknowledge the risk and potential of ALGN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. You can visit our Homepage for Latest News Update
